No takes yet. Share an insight, caveat, or question.
Phase II trial shows ctDNA detection improves clinical decision-making for organ preservation in rectal cancer.
Loree et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: